Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
Clinical trial NCT03657641 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03657641
- Sponsor
- University of Southern California
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-21
- Primary completion
- 2023-02-27
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.